CTRI/2025/08/092579尚未招募不适用
Comparison of topography with TEE derived formula for optimum depth of insertion of right internal jugular vein catheter in pediatric patients
Department of Anaesthesia and Intensive Care1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2025年8月25日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 62
- 试验地点
- 1
- 主要终点
- Incidence of optimum depth of insertion of right internal jugular vein catheter
研究概览
简要总结
This trial is a randomized, single blind, parallel group trial being conducted at a single centre in India in having a sample size of 62.The primary objective of the study is to compare the topography method with TEE derived formula method for the incidence of optimum depth of insertion of right internal jugular vein central venous catheter using chest radiograph in pediatric patients and secondary objectives include access time, guidewire time, incidence of arrhythmias while insertion and incidence of repositioning of central venous catheter.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 2.00 Year(s) 至 12.00 Year(s)（—）
- 性别
- All
入选标准
- •All patients requiring insertion of right internal jugular vein central venous catheter.
排除标准
- •Coagulopathy, Infection at local site, Presence of arrythmias, Deformity of neck(scars, mass etc.) or chest (barrel chest, pigeon chest).
结局指标
主要结局
Incidence of optimum depth of insertion of right internal jugular vein catheter
时间窗: 18 months
次要结局
- Need for repositioning(assessed immediately after insertion of catheter)
- Incidence of arrythmia(assessed immediately after insertion of catheter)
研究者
Dr Yukta Singh
Vardhman Mahavir Medical College and Safdarjung hospital
研究点 (1)
Loading locations...
相似试验
尚未招募
3 期
Clinical trial to evaluate effect of local application of Sharapunkha Malahar in the management of infected woundCTRI/2024/10/074600Dr Raut Rohit Ashok30
尚未招募
不适用
A Study Comparing Fluoride-Based Fillings and Regular Composite Fillings for Back TeethCTRI/2026/01/102610TPCTs Terna Dental College50
尚未招募
3 期
A phase III study to examine effectiveness, safety, pharmacokinetics, and immunogenicity of test brentuximab vedotin (ZRC-3318), administered in combination with chemotherapy, in patients with previously untreated stage III or IV classical Hodgkin lymphomaCTRI/2025/07/091606Zydus Lifesciences Limited201
招募中
2/3 期
This is a comparative Phase II/ III study of bevacizumab with ranibizumab in an eye condition called Wet AMD. A total of 202 subjects are planned to be enrolled in this study, the primary outcome is to evaluate the efficacy of RLS bevacizumab in improving vision.CTRI/2025/05/087515Reliance Life Sciences Pvt Ltd202
招募中
2 期
Clinical Study To Evaluate Effectiveness Of Shatavari Ghrita Aaschyotana In Computer Vision SyndromeCTRI/2025/10/096017DHARMARAJ BHUSHAN BHOITE80